Appetite Stimulant Market Report 2026

Appetite Stimulant Market Overview

• Appetite Stimulant market size has reached to $1.9 billion in 2025 • Expected to grow to $2.86 billion in 2030 at a compound annual growth rate (CAGR) of 8.5% • Growth Driver: The Rising Prevalence Of Chronic Diseases Is Fueling The Market Growth Due To Increasing Demand For Nutritional Support • Market Trend: The Role Of Ayurvedic Products In Enhancing Digestion And Nutrient Absorption • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Appetite Stimulant Market?

Appetite stimulant refers to any substance or product designed to increase an individual’s appetite, particularly when experiencing a loss of hunger due to medical conditions, treatments, or other factors. These stimulants influence hormones or brain functions that control hunger signals, promoting the desire to eat. The main types of appetite stimulants are prescription, over-the-counter, and natural. Prescription appetite stimulants are medications used under medical supervision to boost hunger in individuals experiencing severe appetite loss due to conditions such as cancer, HIV/AIDS, or chronic illness. These stimulants are available in various formulations, including liquid formulations, powder formulations, capsules and tablets, and functional foods. They are distributed through various channels, such as hospital pharmacies, online pharmacies, and retail pharmacies, and are used by a range of end-users, including hospitals, homecare providers, and specialty centers.

What Is The Appetite Stimulant Market Growth Forecast?

The appetite stimulant market size is expected to see strong growth in the next few years. It will grow to $2.86 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to personalized nutrition demand, homecare treatment expansion, functional food innovation, appetite loss management, chronic disease survival rates. Major trends in the forecast period include growing use in chronic disease management, increased adoption in geriatric nutrition, rising preference for natural appetite stimulants, expansion of functional food-based formulations, growth of homecare nutritional support.

Global Appetite Stimulant Market Segmentation

1) By Type: Prescription, Over The Counter, Natural 2) By Formulation Type: Liquid Formulations, Powder Formulations, Capsules And Tablets, Functional Foods 3) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy 4) By End-Users: Hospitals, Homecare, Speciality Centres Subsegments: 1) By Prescription: Synthetic Appetite Stimulants, Cannabinoids, Corticosteroids, Antidepressants 2) By Over The Counter (OTC): Herbal Supplements, Amino Acids, Vitamins And Minerals, Probiotics 3) By Natural: Ginger, Fenugreek, Cannabis, Zinc Supplements

What Is The Driver Of The Appetite Stimulant Market?

The rising prevalence of chronic diseases is expected to propel the growth of the appetite stimulant market going forward. A chronic disease is a long-term medical ailment or illness that usually lasts three months or more and frequently worsens with time. The rising prevalence of chronic diseases is primarily attributed to poor diet, as unhealthy eating habits, such as high consumption of processed foods, sugars, and unhealthy fats, contribute to conditions such as obesity, diabetes, and cardiovascular diseases. Appetite stimulates help with chronic diseases by enhancing overall outcomes and nutritional status by boosting hunger and food consumption, which may help people acquire or maintain weight. For instance, in September 2023, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, there were 41 million deaths, which is 74% of those caused by non-communicable diseases (NCDs) or chronic diseases every year globally. There were 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. Therefore, the rising prevalence of chronic diseases is driving the growth of the appetite stimulant industry.

Key Players In The Global Appetite Stimulant Market

Major companies operating in the appetite stimulant market are Bristol Myers Squibb, Novartis AG, Solvay Pharmaceuticals, Lupin Limited, TIL Healthcare Private Limited, Zeon Lifesciences Limited, Apex Laboratories Private Limited, Nuray Chemicals Private Limited, Arlak Biotech Private Limited, AdvaCare Pharma USA LLC, Dwarkesh Pharmaceuticals Private Limited, Par Pharmaceutical Companies Inc., Salvus Healthcare Private Limited, Epitome Pharmaceuticals Private Limited, Abiba Pharmacia Private Limited, Pharmika India Private Limited, Wellona Pharma, SiNi Pharma, Vibcare Pharma Private Limited, Mayons Pharmaceuticals Private Limited

Global Appetite Stimulant Market Trends and Insights

Major companies operating in the appetite stimulant market are focusing on promoting innovative products such as ayurvedic appetite stimulants to attract health-conscious consumers. An Ayurvedic appetite stimulant is a natural remedy made from traditional herbs that helps increase appetite by stimulating digestive fire, enhancing enzyme secretion, and improving nutrient absorption. For instance, in October 2024, Lupin Limited, an India-based pharmaceutical company, announced the flag-off of its Aptivate Achi Bhookh Fest to promote healthy eating habits and nutrition awareness among children through interactive activities and expert-led sessions, with plans to expand the campaign to reach 250,000 people across schools and residential areas. Aptivate is an ayurvedic appetite stimulant for children designed to help parents promote healthy eating habits. The product plays a key role in LupinLife's initiatives, including the Aptivate Achi Bhookh Fest, which encourages optimal nutrition and strong immunity in children.

What Are Latest Mergers And Acquisitions In The Appetite Stimulant Market?

In January 2025, Zuellig Pharma Corporation, a Singapore-based company specializing in healthcare distribution and pharmaceutical solutions, acquired Propan from ADP Pharma Corporation for an undisclosed amount. With this acquisition, Zuellig Pharma aims to strengthen its position in the consumer health segment by expanding its portfolio with a trusted appetite stimulant and multivitamin brand, enhancing its ability to deliver high-quality healthcare solutions tailored to the diverse nutritional needs of various age groups. ADP Pharma Corporation is a Philippines-based pharmaceutical company specializing in appetite stimulants.

Regional Insights

North America was the largest region in the appetite stimulant market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Appetite Stimulant Market?

The appetite stimulant market consists of sales of cyproheptadine, mirtazapine, and anamorelin. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Appetite Stimulant Market Report 2026?

The appetite stimulant market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the appetite stimulant industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.